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Biological Actions of Nitroarenes
in Short-Term Tests on Salmonella,
Cultured Mammalian Cells and Cultured
Human Tracheal Tissues: Possible
Basis for Regulatory Control
by Takashi Sugimura* and Shozo Takayamat
Pure synthetic nitropyrene compounds were subjected to a mutation test using Salmonella
typhimurium TA 98 and TA 100 with and without S9 mix, a metabolic activation system.
Dinitropyrenes were highly mutagenic. Among them, 1,8-dinitropyrene was the most potent
mutagen, producing940,000 revertants ofTA98/,ug. 1,3,6-Trinitropyrene and 1,3,6,8-tetranitropyrene
werealso highlymutagenic, producing 708,000 and221,000revertants/,Lg, respectively. 1-Nitropyrene
was weakly mutagenic. All nitropyrenes were more mutagenic towards TA 98 than TA 100, and
all mutagenic activities were abolished by the presence of S9 mix. Di- and trinitropyrenes were
demonstrated to be mutagenic to Chinese hamster lung cells without metabolic activation, by
using diphtheria toxin resistancy as a marker. The range ofmutagenic potential ofnitropyrenes
was much narrowerwith cultured mammalian cells than with Salmonella. 1-Nitropyrene was not
mutagenic. 1,6-Dinitropyrene and 1-nitropyrene induced unscheduled DNA synthesis in epithe-
lial cells of in vitro cultured human bronchi, as did diol-epoxides of benzo[a]pyrene, while
benzo[a]pyrene itself was inert. 1-Nitropyrene and 3-nitrofluoranthene produced subcutaneous
fibrosarcomas at the loci ofinjections in the backs ofrats. Tumors were found in 47% and 40% of
animals with total doses of40 mgof1-nitropyrene and 30 mgof3-nitrofluoranthene, respectively.
The biomedical significance of nitroarenes is discussed.
Introduction
Nitroarenes have been reported to show fairly
strong mutagenicity in Salmonella typhimurium,
and their mutagenic activities have been demon-
strated without addition ofthe metabolic activation
system, S9 mix. The specific mutagenic activities of
somenitroarenes are veryhigh, andthesecompounds
have been named supermutagens (1). Some nitro-
arenes are air pollutants (2) and are present in
automobile exhausts (3) and carbon blacks (4). Thus
thebiomedicalimpact, andespeciallythesignificance
for human carcinogenesis, of these nitroarenes is
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being seriously considered. However, it is impossi-
ble to quantitate their health hazard precisely from
data on Salmonella typhimurium only.
This paper describes recent results on the muta-
genicitiesofnitroarenes onSalmonellatyphimurium
and on cultured Chinese hamster lung cells. In
addition, data on their induction of unscheduled
DNA synthesis in vitro in cultured human tracheal
tissue and on their in vivo carcinogenicity are
reported. Dataobtained in short-term tests are also
discussed, on the basis ofprevious finding on other
environmental chemicals of a quantitative relation
between carcinogenicity in vivo in rodents and
mutagenicity in Salmonella typhimurium. On the
basis of results of short-term tests, the regulatory
control of these chemicals is also considered. The
experimentalresultsreportedweremainlyobtainedSUGIMURA AND TAKAYAMA
in our own laboratories: no comprehensive survey
of the literature is given.
Microbial Mutation Tests
The preincubation method (5), which is a minor
modification ofAmes' method (6), was used through-
out the work reported here. The TA 98 and TA 100
strains ofSalmonella typhimurium were used. S9
mix was prepared from the liver of rats that had
been treated with PCB.
The chemicals used and their sources were as
follows. 1-Nitropyrene was a generous gift from
Dr. K. Shudo, University of Tokyo, and Dr. H.
Tokiwa, Fukuoka Environmental Research Center.
1,3-, 1,6-and1,8-Dinitropyrenes, 1,3,6-trinitropyrene
and 1,3,6,8-tetranitropyrene were synthesized as
described previously (1) and were generous gifts
from Dr. R. Mermelstein, Xerox Corporation.
3-Nitrofluoranthene was a gift from Dr.H. Tokiwa.
6-Nitrochrysene, 2-nitrofluorene, 9-nitrophenan-
threne, 1-nitrotriphenylene and2-nitrotriphenylene
were synthesized and provided by Prof. T. Kosuge,
Shizuoka College of Pharmacy. The purities of all
these chemicals were confirmed by HPLC, TLC,
NMR and mass spectroscopy.
The specific mutagenicities of these nitroarenes
are shown in Tables 1 and 2. All nitropyrenes
except 1-nitropyrene showed very high specific
mutagenic activities on the basis ofunit weight and
molar concentration. The mutagenicities of nitro-
pyrenes were abolished almost completely by addi-
tion of S9 mix to the preincubation medium, as
reported previously by Rosenkrantz et al. (1) and
Tokiwa et al. (7). Mononitroarenes other than
1-nitropyrene were also mutagenic without S9 mix,
as shown in Table 2. Of these compounds, 2-nitro-
triphenylene and 3-nitrofluoranthene showed espe-
cially high specific mutagenic activities.
Table 1. Mutagenicity of nitropyrenes on Salmonella typhimurium.
Mutagenicity, revertants/,Lg
TA 98 TA 100
-S9 mix + S9 mixa -S9 mix + S9 mixa
1-Nitropyrene 2,000 71 390 169
1,3-Dinitropyrene 561,000 ob 12600 ob
1,6-Dinitropyrene 230,000 b 35,000 ob
1,8-Dinitropyrene 940,000 Oc 115,000 Oc
1,3,6-Trinitropyrene 708,000 ob 119000 ob
1,3,6,8-Tetranitropyrene 221,000 d ,0 od
Benzo(a)pyrene 0 320 0 660
N-Methyl-N'-nitro-N-nitrosoguanidine 0 0 870 0
aio ,LL of S9 used for benzo(a)pyrene and 100 ,uL of S9 for all other compounds.
bUp to 0.1 ,ug/plate was tested.
CUp to 0.02 ,ug/plate was tested.
dUp to 2 pg/plate was tested.
Table 2. Mutagenicities of nitroarenes on Salmonella typhimurium.
Mutagenicity, revertants/,ug
TA 98 TA 100
-S9 mix +S9 mixa -S9 mix + S9 mixa
3-Nitrofluoranthene 55,900 179 23,600 174
6-Nitrochrysene 69 145 231 443
2-Nitrofluorene 104 42 186 127
9-Nitrophenanthrene 1,300 197 4,400 97
1-Nitrotriphenylene 1,600 36 434 144
2-Nitrotriphenylene 32,400 450 12,900 695
Benzo(a)pyrene 0 320 0 660
N-Methyl-N'-nitro-N-nitrosoguanidine 0 0 870 0
alo ,LL of S9 used for benzo(a)pyrene and 100 ,uL of S9 for other compounds.
172SHORT-TERM TESTS ON NITROARENES
Mutagenicity with Cultured
Chinese Hamster Lung Cells
Induction of resistance to diphtheria toxin has
been used in several laboratories (8,9) as a marker
of mutation of cultured mammalian cells. We also
established a system to detect induction of resis-
tance to diphtheria toxin using Chinese hamster
lung cells (10). Diphtheria toxin catalyzes ADP-
ribosylation of a particular amino acid, diphthamide
in elongation factor 2, with NAD as a donor of
ADP-ribose. Diphthamide is formed by a post-
translational modification ofhistidine in the peptide
chain of elongation factor 2. ADP-ribosylated elon-
gation factor 2 does not show the catalytic property
necessary for protein synthesis and this toxin
eventually kills the cell. Mutant cells resistant to a
high concentration ofdiphtheria toxin are resistant
to ADP-ribosylation of elongation factor 2 by diph-
theria toxin. Post-translational modification of his-
tidine to diphthamide is probably blocked in these
diphtheria toxin-resistant cells. In this system, an
expression time of 7 days was optimal for various
mutagens. Table 3 shows the mutagenic activities
of1-nitropyrene, 1,3-dinitropyrene, 1,6-dinitropyrene,
1,8-dinitropyrene, 1,3,6-trinitropyrene and 1,3,6,8-
tetranitropyrene observed in the absence of meta-
bolic activation. 1,6-Dinitropyrene and 1,8-dinitro-
pyrene werethe mostmutagenic, and 1-nitropyrene
and 1,3,6,8-tetranitropyrene showed scarcely any
mutagenicity. As shown in Figure 1, there is no
apparent correlation between the specific muta-
genic potentials, expressed in equimolar terms, on
Chinese hamster lung cells and Salmonella typhi-
muriumTA 98. Tables 1 and 3 show the mutagenic-
ities ofnitropyrenes, benzo[a]pyrene and N-methyl-
N'-nitro-N-nitrosoguanidine with Salmonella ty-
phimurium and with Chinese hamster lung cells,
respectively. WithSalmonellatyphimurium, nitro-
pyrenes, especially 1,3-dinitropyrene, 1,8-dinitro-
pyrene and 1,3,6-trinitropyrene are much stronger
mutagens than benzo(a)pyrene and (N-methyl-N'-
nitro-N-nitrosoguanidine. But in the system offor-
ward mutation ofChinese hamster lung cells, these
nitropyrenes are only moderately mutagenic.
Induction of Unscheduled DNA
Synthesis in Cultured Human
Trachea
We carried out preliminary studies on unsched-
uled DNA synthesis inhumanbronchial epithelium.
Human tissues were obtained surgically from pa-
tients with lung cancer. The primary or secondary
trachea was cut into small pieces and promptly
incubated in vitro for 6 hr at 37°C in medium con-
taining nitropyrenes and tritiated thymidine. Then
the tissues were fixed, embedded in paraffin and
cut into sections, and sections were dip-covered
with autoradiographic emulsion. Autoradiographic
examination revealed the presence of many epi-
thelial cells undergoing unscheduled DNA synthe-
sis. Table 4 gives results on induction of unsched-
uled DNA synthesis in human tracheal epithelium
treated with nitropyrenes and other carcinogens.
Human tracheal epithelium showed active unsched- O
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Table 3. Mutagenicities of nitropyrenes on Chinese hamster
lung cells.
Compound Mutagenicitya
1-Nitropyrene < 2.0
1,3-Dinitropyrene 74
1,6-Dinitropyrene 210
1,8-Dinitropyrene 152
1,3,6-Trinitropyrene 65
1,3,6,8-Tetranitropyrene < 1.5
Benzo(a)pyrene 23b
N-Methyl-N'-nitro-N-nitrosoguanidine 590
aDTr cells/106 survivors induced by a concentration of 1 PM.
bMutagenicity was assayed with 12.5 ,uL/mL of S9, 0.75mM
NADP and 4.27mM G6P.
Mutagenicity (revertants/pug) in Salmonella
FIGURE 1. Relationship between mutagenicity in Salmonella
typhimurium and mutagenicity in Chinese hamster lung
cells. Abbreviations used: AF-2, 2-(2-furyl-3-(5-nitro-2-
fiuryl)acrylamide; B(a)P, benzo[a]pyrene; DMNA, N,N-
dimethylnitrosoamine; EMS, ethyl methanesulfonate; IQ,
2-amino-3-methylimidazo[4,5-f]-quinoline; MeIQ, 2-amino-3,
4-dimethylimidazo[4,5-flquinoline; MMS, methyl methane-
sulfonate; MNNG, N-methyl-N'-nitro-N-nitrosoguanidine;
MNU, methylnitrosourea; 1-NPY, 1-nitropyrene; 1,3-NPY,
1,3-dinitropyrene; 1,6-NPY, 1,6-dinitropyrene; 1,8-NPY,
1,8-dinitropyrene; 1,3,6-NPY, 1,3,6-trinitiropyrene; 1,3,6,8-
NPY, 1,3,6,8-tetranitropyrene; Trp-P-1, 3-amino-1,4-di-
methyl-5H-pyrido[4,3-b]indole; Trp-P-2, 3-amino-i-methyl-
5H-pyrido[4,3-b]indole.
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Table 4. Induction of unscheduled DNA synthesis in human
tracheal epithelial cells by nitropyrenes and other carcino-
gens.
Average no.
Dose of of grains/
Compound compound, M nucleus
1-Nitropyrene 10-4 3
1,6-Dinitropyrene 104 14
BP 4 x 10 0.5
BPDE I 3 x 107 25
BPDE II 3 x 1le 23
ENU 3.2 x 103 9
4NQO 3.2 x 10 13
Control 0.3-0.5
uled DNA synthesis in response to nitropyrenes,
but 1,6-dinitropyrene was more effective than 1-
nitropyrene. In this system, benzo(a)pyrene (BP)
was not effective, but ultimate reactive forms of
benzo(a)pyrene, namely(-+)-(7,B8ao)-dihydroxy-(9a,
10a)-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene (BP
DE I) and (+)-(7,B 8a)-dihydroxy-(93,B101,)-epoxy-
7,8,9,10-tetrahydrobenzo(a)pyrene (BPDE II), were
very effective in inducing unscheduled DNA syn-
thesis, being more effective than nitropyrenes and
other representative carcinogens [ethylnitrosourea
(ENU) and 4-nitroquinoline 1-oxide (4NQO)].
Apparently human tracheal tissues in vitro can-
not activate benzo(a)pyrene, but can activate
nitropyrenes in the absence ofthe S9 mix metabolic
activation system, as has been observed with
Chinese hamster lung cells. Human tracheal epi-
thelial cells should have nitroreductase(s), which
converts nitropyrenes to ultimate reactive forms.
This experiment suggests that nitropyrenes could
be more important than benzo(a)pyrene as a cause
of human cancer.
In Vivo Carcinogenicity in Rats
Since only limited amounts ofthe test compounds
wereavailable, 1-nitropyreneand3-nitrofluoranthene
were injected subcutaneously into rats.
Male 8-week-old F344/DuCrj Fischer rats were
given 2 mg of 1-nitropyrene twice weekly 20 times
or 2 mg of 3-nitrofluoranthene twice weekly 15
times. These chemicals were given as solutions in
dimethyl sulfoxide at a concentration of 10 mg/mL.
Control rats received 0.2 ml of dimethyl sulfoxide
twice weekly 20 times. During the experimental
period of 12 months, the incidences oftumors at the
site of injection were 47% with 1-nitropyrene and
40% with 3-nitrofluoranthene, as shown in Table 5.
Histologically, most of the tumors were malignant
fibrous histiocytomas. Some tumors were transplant-
able in the same strain of rats (11). The carcino-
genic potencies of chemicals cannot be determined
from data on the effect of their subcutaneous
injection at one dose level. However, considering
the total dose injected, and the fact that the first
tumor was found on the 162nd experimental day
with 1-nitropyrene and the 277th day with 3-nitro-
fluoranthene, it may be concluded that these two
compounds are not very potent carcinogens.
Quantitative Relation between
Carcinogenic and Mutagenic
Potencies
Most typical carcinogens have been shown to be
mutagenic. Some, such as N-methyl-N'-nitro-N-
nitrosoguanidine andN-nitroso-ethylurea, are direct
acting chemicals, while others, such as 4-nitroquino-
line 1-oxide and nitrofurylfurylacrylamide, are acti-
vated by enzymes present in most microbes and
cultured mammalian cells. A third class of com-
pounds, including benzo(a)pyrene and acetylamino-
fluorene, has to be metabolically activated by
microsomal enzymes before conversion to ultimate
forms.
Many compounds have been newly identified as
mutagens by the Salmonella test. These include
about 10heterocycicaminesisolatedfrompyrolysates
of amino acids and proteins. Some of these have
been shown to be carcinogenic (12, 13). In early
studies a fairly good overlap was found between
bacterial mutagenicity and carcinogenicity (14-16).
It was once claimed that the mutagenic potency
was also quantitatively correlated with the carcino-
genic potency (17). However, based on ourfindings,
as shown in Figure 2, the carcinogenic potency,
expressed as the TD50, and the mutagenic potency
in Salmonella typhimurium are not correlated
linearly. Trp-P-1 (3-amino-1,4-dimethyl-5H-pyrido-
[4,3-b]indole) and Trp-P-2 (3-amino-1-methyl-5H-
pyrido[4,3-b]-indole), obtained from the pyrolysate
of tryptophan, and Glu-P-1 (2-amino-6-methyldi-
pyrido[1,2-a:3',2'-d]imidazole) andGlu-P-2(2-amino-
dipyrido[1,2-a:3',2'-d]imidazole), obtained from the
pyrolysate of glutamic acid, are almost equally as
mutagenictoSalmonellatyphimurium, asaflatoxin
B1, but their carcinogenicities are about the same
as that of o-aminoazotoluene, which is about one
thousandth as mutagenic as aflatoxin B1.
A serious discrepancy between the results of
short-term assay tests and carcinogenicity is seen
in the case of the flavonoid, quercetin: the muta-
genicity ofquercetiniswellestablished (18, 19), but
its carcinogenicity in vivo could not be demon-
strated in mice (20), rats (21) or hamsters (22), and
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Table 5. Inductions of tumors by 1-nitropyrene and 3-nitrofluoranthene in F344/DuCrj rats.
Day when tumors
Total dose, Effective no. No. of rats with detected, no. of days
Group Carcinogen mg/rat of ratsa tumors, % after first injection
I 1-Nitropyrene 40 17 8 (47) 162, 186, 200, 221,
269, 269, 330, 333
II 3-Nitrofluoranthene 30 10 4 (40) 277, 277, 298, 319
I 0 20 0 ( 0)
aEffective rats are those that survived beyond day 162, when the first tumor was found in a rat treated with 1-nitropyrene.
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FIGURE 2. Relationship between carcinogenicity and mutage-
nicity in Salmonella typhimurium. Abbreviations used:
p-AAB, p-aminoazobenzene; 4-AABi, 4-acetylaminobiphenyl;
2-AAF, 2-acetylaminofluorene; o-AAT, o-aminoazotoluene;
AaC, 2-amino-9H-pyrido-[2,3-blindole; AF-2, 2-(2-furyl)-3-
(5-nitro-2-fuiryl)acrylamide; AFB1, aflatoxin B1; BBN, N-
butyl-N-butanolnitrosamine; BNU,N-n-butyl-N-nitrosourea;
BNUT, N-n-butyl-N-nitrosourethane; B(a)P, benzo[a]pyrene;
BZD, benzidine; DAN, 2,4-diaminoanisole; DBA, dibenz[a,
h]anthracene; DBE, 1,2-dibromoethane; DBNA, N,N,di-n-
butylnitrosamine; DBP, 1,2-dibromochloropropane; DMAS,
4-dimethylaminostilbene; DMBA, 7,12-dimethylbenz[a]-
anthracene; DMNA, N,N-dimethylnitrosamine; El, ethylene-
imine; Glu-P-1, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole;
Glu-P-2, 2-aminodipyrido[1,2-a:3',2'-d]imidazole; HFA, N-
hydroxy-2-acetylaminofluorene; HYD, hydralazine; MAM
acetate, methylazoxymethanol acetate; 3MCA, 3-methylchol-
anthrene; 3'-MDAB, 3'-methyl-4-dimethylaminoazobenzene;
MeAaC, 2-amino-3-methyl-9H-pyrido[2,3-b]indole; MMS,
methyl methanesulfonate; MNU, N-methyl-N-nitrosourea;
MOCA, 4,4'-methylenebis(2-chloro-aniline); 2NA, 2-naphthyla-
mine; 4NQO, 4-nitroquinoline 1-oxide; PHE, phenacetin; PI,
propyleneimine; ,B-PL, j-propiolactone; PS, propane sultone;
STRC, sterigmatocystin; TCE, trichloroethylene; TDS,
toluenediamino sulfate; TOX, toxaphene; TRIS, tris(2,3-
dibromopropylphosphate); Trp-P-1, 3-amino-1,4-dimethyl-5H-
pyrido[4,3-b]indole; Trp-P-2, 3-amino-1-methyl-5H-pyrido[4,3-
b]indole; VC, vinyl chloride.
although it is reported to be carcinogenic in Nor-
wegian rats (23), it clearly does not have a carcino-
genic potency comparable toits mutagenicpotency,
which is equivalent to that ofbenzo[a]pyrene. Some
nitroarenes are strongly mutagenic, but this does
not necessarily indicate that they are potent carcin-
ogens; some are only weakly mutagenic, but this
does not necessarily mean that they are only
weakly carcinogenic.
General Comments
The carcinogenic process is divided into two
steps, initiation and promotion. Mutagenicity may
be closely related to initiation, but may not be
directly related to promotion; mutagenicity may
indicate a capacity to produce DNA damage. It was
recently suggested that DNA damage that results
in chromosomal structural change may be more
relevant to the initiation step than that yielding
point mutations. Little is known about the molecu-
larmechanismofDNAdamagecausedbynitroarenes,
and it is still unknown whether nitroarenes have
the tumor promoting activity expected of most
typical carcinogens.
Furthermore the nitroarenes present in automo-
bile exhaust should be carefully analyzed, since it is
known that automobile exhaust shows definite
mutagenic activity and this may well be due to
nitroarenes. The incidence of lung cancer has
increased greatly in many industrialized countries.
This could largely be due to cigarette smoking, but
it is noteworthy that many cases oflung cancer can
not be explained by active or passive smoking. The
information available at present on the relation
between data obtained in short-term tests and in
long-term in vivo animal tests is not yet sufficient
to warrant taking any regulatory measures, espe-
cially in the case of automobile exhaust and nitro-
arenes, but the etiological factors responsible for
lung cancer should be studied in more detail.
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